Quantcast

Latest Erythropoietin Stories

2014-10-14 08:31:25

DUBLIN, Oct. 14 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Europe Biosimilars Market & Pipeline Insight" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Biosimilars have emerged as one of the most promising segment of the European pharmaceutical industry in recent years. The biosimilars segment has been experiencing a steady growth driven by patent expiration of blockbuster drugs, amenable regulatory framework, economic...

2014-08-27 23:14:02

AllMed webinar provides in-depth review of the latest standard of care for the use of ESAs in the treatment of Chronic Kidney Disease. Portland, OR (PRWEB) August 27, 2014 The use of ESAs to treat anemia of CKD can improve quality of life and may eliminate the need for blood transfusion and associated risks, but not without controversy. During a recent AllMed webinar, Dr. Zanhua Yi, board certified in hematology, oncology, and internal medicine, discussed issues related to determining...

2014-08-13 16:26:02

THOUSAND OAKS, Calif., Aug. 13, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) initiated a voluntary recall on June 26, 2014 for nine packaged lots of Aranesp(®) (darbepoetin alfa) (500 mcg) prefilled syringes from non-U.S. distributors, wholesalers and a number of hospital pharmacies due to the potential presence of cellulose and/or polyester particles observed in a small number of syringes during a routine quality examination. Lots 1042847, 1044141A, 1044141C, 1044141D, 1046891A, 1046891B,...

2014-07-21 12:25:25

PORTLAND, Oregon, July 21, 2014 /PRNewswire/ -- A new report by Allied Market Research titled, "Global biosimilars/follow-on-biologics market (types, applications and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020", suggests that the global biosimilars market would reach $35 billion by 2020 from the estimated $1.3 billion in 2013. Deeper penetration with clearer...

2014-07-03 10:57:32

Society for Experimental Biology Austrian researchers have found that jetlag has severe effects on red blood cells, possibly explaining the high incidence of heart disease seen in shift workers. However, these effects can be counterbalanced by fresh, young red blood cells – making blood donations a potential therapy for shift workers. The scientists, led by Dr Margit Egg (University of Innsbruck), worked on zebrafish (Danio rerio), a model organism which, like humans, is active...

2014-07-02 12:15:29

The JAMA Network Journals In patients with a traumatic brain injury (TBI), neither the administration of the hormone erythropoietin (EPO) or maintaining a higher hemoglobin concentration through blood transfusion resulted in improved neurological outcome at 6 months, according to a study in the July 2 issue of JAMA. Transfusing at higher hemoglobin concentrations was associated with a higher risk of adverse events. Patients with severe traumatic brain injury commonly develop anemia....

2014-06-16 23:04:46

GIA announces the release of a comprehensive global report on Growth Factors (Blood and Tissue) markets. Global market for Growth Factors (Blood and Tissue) is forecast to reach US$48 billion by 2020, driven by growing demand for effective, cost-efficient therapeutics, and increasing significance of growth factors in the treatment of chemotherapy-associated anemia and neutropenia. San Jose, California (PRWEB) June 16, 2014 Follow us on LinkedIn – Fuelled by the growing importance of...

2014-05-21 08:29:46

BOULDER, Colo., May 21, 2014 /PRNewswire/ -- People are individuals. They differ. Patients differ too. Yet, patients with chronic diseases are frequently treated using protocols that ignore patient variability and that have rarely been tested in diverse populations. They do not take into account characteristics that may influence responses to treatment such as age, race, gender, and co-morbid illnesses. Continuous Quality Improvement (CQI) is an iterative, continuing, process used in...

2014-05-20 20:22:02

NEW YORK and BOULDER, Colo., May 20, 2014 /PRNewswire-USNewswire/ -- People are individuals. They differ. Patients differ too. Yet, patients with chronic diseases are frequently treated using protocols that ignore patient variability and that have rarely been tested in diverse populations. They do not take into account characteristics that may influence responses to treatment such as age, race, gender, and co-morbid illnesses. Continuous Quality Improvement (CQI) is an iterative, continuing,...

2014-04-11 12:05:26

Targeting cytomegalovirus may help restore health A virus that is present in most people in a latent state may induce or exacerbate anemia in patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings point to a new therapeutic target for affected individuals. Chronic kidney disease (CKD) patients and kidney transplant recipients often develop anemia, or low levels of red blood cells. This...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.